Advancing Healthcare Through Personalized Medicine
Autor Priya Haysen Limba Engleză Hardback – 28 sep 2021
An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine.
Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence.
A work that advocates for a patient-centered approach, Advancing Healthcare Through Personalized Medicine, Second Edition is an invaluable text for clinicians, healthcare providers, and patients.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 327.14 lei 6-8 săpt. | |
| CRC Press – 13 mar 2017 | 327.14 lei 6-8 săpt. | |
| Hardback (2) | 953.51 lei 6-8 săpt. | |
| CRC Press – 18 sep 2018 | 953.51 lei 6-8 săpt. | |
| Springer International Publishing – 28 sep 2021 | 1161.84 lei 39-44 zile |
Preț: 1161.84 lei
Preț vechi: 1222.99 lei
-5% Nou
Puncte Express: 1743
Preț estimativ în valută:
222.36€ • 234.58$ • 185.31£
222.36€ • 234.58$ • 185.31£
Carte tipărită la comandă
Livrare economică 30 decembrie 24 - 04 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030800994
ISBN-10: 3030800997
Pagini: 745
Ilustrații: XXIV, 745 p. 98 illus., 94 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 1.54 kg
Ediția:2nd ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030800997
Pagini: 745
Ilustrații: XXIV, 745 p. 98 illus., 94 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 1.54 kg
Ediția:2nd ed. 2021
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
V-ar putea interesa
-
-25%Preț: 240.12 lei319.75 lei -
USMLE Step 2 CK PlusAbdillahi Omar-16%Preț: 288.93 lei343.63 lei -
-5%Preț: 81.10 lei85.37 lei -
-23%Preț: 294.22 lei381.17 lei -
Step-Up to MedicineSteven Agabegi MD-27%Preț: 316.83 lei432.53 lei
Cuprins
- Introduction: Biomedical Innovation and Policy in the Twenty-First Century
- The Rise of Genomics and Personalized Medicine
- Patient Narratives: Personalized Medicine in the Field
- Alliances: Knowledge Infrastructures, and the Digitization of Precision Health
- Tumor Genesis and Precision Oncology
- Trends in Precision Oncology and Precision Medicine 2.0
- Personalized medicine’s impact on disease
- The Genome in the Clinic and Boardroom: Biomarkers, Diagnosis, Treatment, and Education
- A New Set of Clinical tools for Physicians
- Legislation, Reimbursement and the Regulatory Landscape
- Translational personalized medicine: Molecular profiling, druggable targets, and clinical genomic medicine
- The Health Economics of Personalized Precision Medicine
- Moral, Societal and Ethical Issues: Claims, Consequences, and Caveats
- Conclusion
Notă biografică
Priya Hays
Hays Documentation Specialists, LLC
San Mateo
California
USA
Priya Hays, Ph.D. is an accomplished science writer, having written and published four books as well as having authored over twenty publications in journals as varied as the Bulletin of Science, Technology and Society, L’Esprit Createur, Interdisciplinary Literary Studies, Genetics in Medicine, Journal of Clinical Investigation and Studies, and Preventive Medicine, Epidemiology and Public Health. The publication of the first edition of Advancing Healthcare Through Personalized Medicine brought Dr. Hays much prominence and credibility in the personalized and genomic medicine field. She was elected to three prestigious medical societies (as Allied Physician/Doctoral Scientist of the American Society of Clinical Oncology; as Affiliate Member of the American College of Medical Genetics and Genomics; and as Member of the Society for Immunotherapy of Cancer). Additionally, she has published an editorial on personalized medicine in the journal Genetics in Medicine and a paper in collaboration with two physicians at the University of California, San Diego Health System on clinical care of patients taking immunotherapies and managing their adverse effects in the journal Future Oncology. She is also serving as Guest Editor for an upcoming volume on cancer immunotherapies in the Cancer Treatment and Research series. She completed her postdoctoral research fellowship in the Division of Hematology/Oncology, Department of Medicine, at Dartmouth Medical School. She has an A.B. with Honors from Dartmouth College in Biochemistry and Comparative Literature, an M.S. in Genetics from the University of California, Davis, and a Ph.D. in Literature from the University of California, San Diego.
Hays Documentation Specialists, LLC
San Mateo
California
USA
Priya Hays, Ph.D. is an accomplished science writer, having written and published four books as well as having authored over twenty publications in journals as varied as the Bulletin of Science, Technology and Society, L’Esprit Createur, Interdisciplinary Literary Studies, Genetics in Medicine, Journal of Clinical Investigation and Studies, and Preventive Medicine, Epidemiology and Public Health. The publication of the first edition of Advancing Healthcare Through Personalized Medicine brought Dr. Hays much prominence and credibility in the personalized and genomic medicine field. She was elected to three prestigious medical societies (as Allied Physician/Doctoral Scientist of the American Society of Clinical Oncology; as Affiliate Member of the American College of Medical Genetics and Genomics; and as Member of the Society for Immunotherapy of Cancer). Additionally, she has published an editorial on personalized medicine in the journal Genetics in Medicine and a paper in collaboration with two physicians at the University of California, San Diego Health System on clinical care of patients taking immunotherapies and managing their adverse effects in the journal Future Oncology. She is also serving as Guest Editor for an upcoming volume on cancer immunotherapies in the Cancer Treatment and Research series. She completed her postdoctoral research fellowship in the Division of Hematology/Oncology, Department of Medicine, at Dartmouth Medical School. She has an A.B. with Honors from Dartmouth College in Biochemistry and Comparative Literature, an M.S. in Genetics from the University of California, Davis, and a Ph.D. in Literature from the University of California, San Diego.
Textul de pe ultima copertă
This book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it helps to mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to the underlying concepts at the heart of personalized medicine.
An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine.
Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence.
A work that advocates for a patient-centered approach, Advancing Healthcare Through Personalized Medicine, Second Edition is an invaluable text for clinicians, healthcare providers, and patients.
An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine.
Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence.
A work that advocates for a patient-centered approach, Advancing Healthcare Through Personalized Medicine, Second Edition is an invaluable text for clinicians, healthcare providers, and patients.
Caracteristici
Provides the most up-to-date and current information in a very fast-paced area of medicine
Discusses the implementation of personalized medicine through expert voices and literature reviews
Introduces the reader to these underlying concepts at the heart of personalized medicine
Discusses the implementation of personalized medicine through expert voices and literature reviews
Introduces the reader to these underlying concepts at the heart of personalized medicine
Recenzii
‘Dr. Hays has produced a detailed tour de force that provides a comprehensive overview of the rapidly growing field of personalized, precision medicine. This book will help the educated layman understand how medicine is about to be transformed and will serve as an excellent reference for those pushing the field forward. An essential read for patients and caregivers alike!’Pieter R. Cullis, PhD, FRSC, Director, Life Sciences Institute; Director, NanoMedicines Research Group; Chair, Personalized Medicine Initiative; Professor, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada; author ‘The Personalized Medicine Revolution: How Diagnosing and Treating Disease Are About to Change Forever’
‘…rich with present thinking on this complex landscape [and] gives valuable perspective on personalized medicine, key terms, thoughts and findings of more than 60 leaders … and a brief look at economic and ethical issues that need to be faced … a great starting point for executives, professionals, and students’ Jane Binger, EdD, RN, former Senior Research Officer and Leader, Individualized Medicine & Precision Medicine Strategy Recommendation Task Force and Individualized Medicine Business Planning Task Force at Sutter Health; currently Senior Advisor, Center of Excellence in Diversity in Education, Stanford University School of Medicine, USA
‘…rich with present thinking on this complex landscape [and] gives valuable perspective on personalized medicine, key terms, thoughts and findings of more than 60 leaders … and a brief look at economic and ethical issues that need to be faced … a great starting point for executives, professionals, and students’ Jane Binger, EdD, RN, former Senior Research Officer and Leader, Individualized Medicine & Precision Medicine Strategy Recommendation Task Force and Individualized Medicine Business Planning Task Force at Sutter Health; currently Senior Advisor, Center of Excellence in Diversity in Education, Stanford University School of Medicine, USA
Descriere
Descriere de la o altă ediție sau format:
This innovative book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it will help mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to underlying concepts at the heart of personalized medicine - pharmacogenomics, targeted therapies and individualized diagnosis and treatment - and shows how, with the advent of genomic technologies, clinicians will have the capability to predict and diagnose disease more efficiently.
This innovative book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it will help mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to underlying concepts at the heart of personalized medicine - pharmacogenomics, targeted therapies and individualized diagnosis and treatment - and shows how, with the advent of genomic technologies, clinicians will have the capability to predict and diagnose disease more efficiently.